急性淋巴細胞白血病；急性淋巴細菌性白血病
Methods Nursing experiences for caring 46 cases with acute lymphocytic leukemia during chemotherapy were retrospectively analyzed.
方法回顧性總結46例急性淋巴細胞白血病病人化療期間的護理經驗。
Acute lymphocytic leukemia and acute myelogenous leukemia are each composed of young cells, known as lymphoblasts or myeloblasts. These cells are sometimes called blasts.
“急性淋巴細胞性白血病”和“急性髓細胞性白血病”各由不同的幼稚細胞如“成淋巴細胞”或“成髓細胞”組成，有時也稱為“母細胞”。
Objective: To investigate the relation between multiple chemosensitivity test in vitro and chemical therapeutic efficacy in vivo in acute lymphocytic leukemia (ALL).
目的：探讨急性淋巴細胞性白血病（ALL）體外聯合藥敏試驗結果與體内化療療效的關系。
Acute lymphocytic leukemia is the most common type of cancer in children, and treatments result in a good chance for a cure.
急性淋巴細胞性白血病是兒童最為常見的癌症，而且治療能帶來疾病治愈的好機會（譯者：指治愈希望較大）。
METHODS:A total of 25 patients with acute leukemia received HLA-identical sibling allo-PBSCT. All cases included 20 cases with acute myeloid leukemia and 5 cases with acute lymphocytic leukemia.
方法：25例急性白血病患者接受HLA相合同胞的異基因外周血造血幹細胞移植，其中急性髓系白血病20例，急性淋巴細胞白血病5例。
Acute lymphocytic leukemia can also occur in *****s, though the prognosis is not as optimistic.
急性淋巴細胞性白血病也能發生在成人期，然而預後（譯者：指可能的病程和結局）沒有發生在兒童期那麼樂觀。
Recently, elevated IL-18 levels were found in serum from some leukemia patients, especially those with acute lymphocytic leukemia (ALL) and chronic myeloid leukemia (CML).
近來，研究發現急性淋巴細胞白血病（ALL）和慢性粒細胞白血病（CML）患者血清中IL-18水平高于正常人。
Acute lymphocytic leukemia and acute myelogenous leukemia are each composed of blast cells, known as lymphoblasts or myeloblasts.
急性淋巴細胞白血病和急性粒細胞性白血病均由癌變的母細胞引起，如淋巴母細胞或原始粒細胞。
In acute lymphocytic leukemia, bone pain occurs in approximately 25% of patients at the onset of the disease.
急性淋巴細胞白血病患者中，大概隻有25%的人在初期會感受到骨骼處産生的疼痛。
The methotrexate(MTX) serum concentration of patients with acute lymphocytic leukemia in our hospital during 2003~2006 was monitored by fluorescence polarization immunoassay.
前言：采用熒光偏振免疫分析法，對2003~2006年我院急性淋巴細胞白血病患者MTX血藥濃度進行監測。
Acute lymphocytic leukemia (ALL) is a type of cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made.
急性淋巴細胞性白血病（ALL）是一種發生于血液和骨髓的癌症——骨髓（譯者：此處指紅骨髓）是指作為造血場所的骨内的海綿組織。
Acute lymphocytic leukemia and acute myelogenous leukemia are each composed of young cells, known as lymphoblasts or myeloblasts.
“急性淋巴細胞性白血病”和“急性髓細胞性白血病”各由不同的幼稚細胞如“成淋巴細胞”或“成髓細胞”組成。
Acute lymphocytic leukemia is also known as acute lymphoblastic leukemia and acute childhood leukemia.
急性淋巴細胞性白血病也稱急性淋巴母細胞性白血病，又稱急性兒童期白血病。
FLT3 overexpresses in acute myelogenous leukemia(AML) and B-acute lymphocytic leukemia(B-ALL). FLT3 mutation is the most common gene mutation in AML.
FLT3在急性髓細胞白血病（AML）及急性B淋巴細胞白血病（B-ALL）中有過度表達，其突變是AML中最常見的基因異常。
This study was designed to explore the influence of STI571, a tyrosine kinase inhibitor, on the expression of c kit in the bone marrow cells from patients with acute non lymphocytic leukemia (ANLL).
本研究探索異基因造血幹細胞移植治療急性非淋巴細胞白血病合并腎細胞癌切除術後患者的有效性與安全性。
Objective : TO investigated the therapy effect and prognosis related factors in the Acute Non-lymphocytic leukemia (ANLL) patients.
目的：探讨我院急性非淋巴細胞性白血病（ANLL）患者的治療效果及其預後相關因素。
The plasma concentration of thrombomodulin (TM) were measured in 29 cases of acute non-lymphocytic leukemia (ANLL). Plasma TM level significantly increased in ANLL patients.
本文對29例急性非淋巴細胞白血病（ANLL）患者的血漿血栓調節蛋白（TM）水平進行檢測，發現ANLL組血漿TM水平比正常組明顯升高。
In high concentrations, preparations have shown to inhibit cells from acute lymphocytic and acute granulocytic leukemia.
在高濃度，籌備工作已經表明，以抑制急性淋巴細胞白血病和急性粒細胞白血病細胞。
Chronic lymphocytic leukemia and chronic myelogenous leukemia usually progress slowly compared to acute leukemias.
相對于急性白血病，慢性淋巴細胞白血病和慢性粒細胞性白血病通常進展緩慢。
Chronic leukemias have few or no blast cells. Chronic lymphocytic leukemia and chronic myelogenous leukemia usually progress slowly compared to acute leukemias.
“慢性”白血病少有或幾乎沒有母細胞。與急性白血病相比，“慢性淋巴細胞性白血病”和“慢性髓細胞性白血病”通常進程相對緩慢。
Methods The experience from 21 cases of children with acute lymphocytic leukemia was summarized.
方法回顧性總結21例急性淋巴細胞白血病患兒化療的護理經驗。
Objective To investigate the clinical significance of DNA detection on diagnosis and therapy in acute lymphocytic leukemia(ALL).
目的探讨DNA檢測對急性淋巴細胞性白血病（ALL）診斷和治療的臨床意義。
急性淋巴細胞白血病（Acute Lymphocytic Leukemia，簡稱ALL）是一種起源于骨髓的惡性血液疾病，屬于白血病的一種亞型。其病理特征為未成熟的淋巴細胞（即淋巴母細胞）在骨髓中異常增生，并迅速取代正常造血細胞，導緻紅細胞、血小闆和健康白細胞數量顯著減少。
目前确切的病因尚不明确，但研究發現與遺傳因素（如唐氏綜合征等染色體異常）、環境暴露（如電離輻射或苯類化學物質）以及免疫系統異常有關。兒童是該疾病的高發群體，約占兒童白血病的75%-80%，但成人患者預後通常較差。
典型症狀包括疲勞（因貧血）、反複感染（因中性粒細胞減少）、異常出血或瘀斑（因血小闆減少）以及骨痛（因骨髓過度膨脹）。部分患者可能出現肝脾腫大或淋巴結腫大。
診斷需結合血液檢查（如全血細胞計數）和骨髓活檢，并通過流式細胞術或免疫分型确認淋巴細胞的異常表型。根據世界衛生組織（WHO）分類标準，ALL可分為B細胞型（占85%）和T細胞型（占15%）。
标準治療包括誘導化療（如長春新堿聯合糖皮質激素）、鞏固化療、維持治療及中樞神經系統預防。對于高危或複發性患者，造血幹細胞移植是重要選擇。近年來，靶向藥物（如酪氨酸激酶抑制劑）和CAR-T細胞療法顯著改善了部分難治性患者的生存率。
參考資料：
急性淋巴細胞白血病（Acute Lymphocytic Leukemia, ALL）是一種快速進展的血液系統惡性腫瘤，以下是其詳細解釋：
ALL是白血病的一種亞型，因淋巴細胞前體（淋巴母細胞）在骨髓中惡性增殖導緻。其特點是未成熟的淋巴細胞異常增生，抑制正常造血功能。根據來源不同，可分為B細胞型和T細胞型。
常見症狀包括貧血（乏力、蒼白）、出血傾向（如鼻衄、瘀斑）、反複感染（因正常白細胞減少）及器官浸潤（如肝脾腫大、骨痛）。
ALL是兒童最常見的白血病類型，占兒童白血病的75%-80%，但成人發病率較低且預後較差。
若需進一步了解治療進展或具體病例管理，可參考醫學文獻或權威指南。
【别人正在浏覽】